HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heena Khan Selected Research

piclamilast

8/2022Neuroprotective Effect of Piclamilast-Induced Post-Ischemia Pharmacological Treatment in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heena Khan Research Topics

Disease

6Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 02/2021
3Ischemia
08/2022 - 01/2022
3Stroke (Strokes)
07/2022 - 08/2021
2Brain Ischemia (Cerebral Ischemia)
08/2022 - 01/2022
2Brain Injuries (Brain Injury)
01/2022 - 09/2021
2Alzheimer Disease (Alzheimer's Disease)
08/2021 - 01/2020
1Neuroinflammatory Diseases
10/2022
1Infarction (Infarctions)
08/2022
1Central Nervous System Diseases (CNS Diseases)
07/2022
1Traumatic Brain Injuries (Traumatic Brain Injury)
07/2022
1Brain Diseases (Brain Disorder)
05/2022
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2022
1Pathologic Processes
03/2022
1Neoplasms (Cancer)
11/2021
1Reperfusion Injury
10/2021
1Brain Edema (Cerebral Edema)
09/2021
1Parkinson Disease (Parkinson's Disease)
08/2021
1Huntington Disease (Huntington's Disease)
08/2021
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2021
1Alcoholism (Alcohol Abuse)
01/2021
1Exotropia (Exophoria)
01/2020
1Ocular Motility Disorders (Convergence Insufficiency)
01/2020
1Esotropia (Esophoria)
01/2020

Drug/Important Bio-Agent (IBA)

3EnzymesIBA
07/2022 - 11/2021
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2022 - 02/2021
1AlkaloidsIBA
10/2022
1demethyleneberberineIBA
10/2022
1BerberineIBA
10/2022
1CaspasesIBA
09/2022
1Caspase InhibitorsIBA
09/2022
1Neuroprotective AgentsIBA
08/2022
1Phosphodiesterase 4 InhibitorsIBA
08/2022
1piclamilastIBA
08/2022
1Ion Channels (Ion Channel)IBA
07/2022
1Thioctic Acid (Lipoic Acid)IBA
07/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
07/2022
1CalpainIBA
05/2022
1Cysteine Proteases (Cysteine Protease)IBA
05/2022
1calpain inhibitorsIBA
05/2022
1Vitamin DFDA LinkGeneric
03/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022
1Sirtuin 1IBA
03/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2022
1NF-kappa B (NF-kB)IBA
03/2022
1ThromboxanesIBA
03/2022
1ProstaglandinsIBA
03/2022
1NeuropeptidesIBA
01/2022
1protocatechuic acidIBA
01/2022
1Deubiquitinating EnzymesIBA
11/2021
1UbiquitinIBA
11/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2021
1Leukotriene Receptors (Leukotriene Receptor)IBA
10/2021
1InterleukinsIBA
09/2021
1Chemotactic FactorsIBA
09/2021
1SirtuinsIBA
08/2021
1Histones (Histone)IBA
08/2021
1Poly (ADP-Ribose) Polymerase-1IBA
02/2021
1Pharmaceutical PreparationsIBA
02/2021
1Ophthalmic Solutions (Eye Drops)IBA
01/2020
1AtropineFDA LinkGeneric
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020

Therapy/Procedure

4Therapeutics
07/2022 - 01/2021